Anticonvulsant activity and selective inhibition of NAD-dependent oxidations in rat brain homogenates by newer mercaptotriazoles.
D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009243:NAD / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D013438:Sulfhydryl Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D014230:Triazoles / Q000138:chemical synthesis / Q000494:pharmacology*
D000927:Anticonvulsants; D013438:Sulfhydryl Compounds; D014230:Triazoles; D009243:NAD